In This Section

Research Funding Impact

Since 1993, the AACR has awarded more than $542 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.

Search/Filter
Category
AACR Career Development AwardsAACR Research GrantsGrantee ImpactGrantee NewsGrantee StoryGrants News
Loading...
AACR – J&J Lung Cancer Innovative Science Grants: Cutting-Edge Approaches to Cut Down Cancer Risk

AACR – J&J Lung Cancer Innovative Science Grants: Cutting-Edge Approaches to Cut Down Cancer Risk

Lung cancer remains the number one cause of cancer-related death. This persistent dismal prognosis has been largely attributed to late-stage diagnosis, when 5-year survival rates are less than 5%. Although the potential of lung cancer screening to reduce lung cancer-related mortality has been demonstrated, there remains a need for more effective and less invasive early detection methods. The AACR-Johnson & Johnson Lung Cancer Innovative Science Grants are fueling...

Category: Grants News
Learn More
Bispecific Anti-PD-1/PD-L1 Antibody’s Dual Impact in Ovarian Cancer

Bispecific Anti-PD-1/PD-L1 Antibody’s Dual Impact in Ovarian Cancer

Despite demonstrated success in many solid tumor types, immune checkpoint blockade (ICB) agents have minimal efficacy in high grade serous ovarian cancer (HGSC). In this study, the authors describe a novel bispecific anti-PD-1/PD-L1 antibody, which showed increased anti-tumor efficacy compared to mono-specific anti-PD-1 or anti-PDL1. The researchers also...

Category: Grantee Impact
Learn More
From Bench to Community: Dr. Channing Der on PanCAN-AACR Grants Impact

From Bench to Community: Dr. Channing Der on PanCAN-AACR Grants Impact

Dr. Channing Der serves as the Sarah Graham Kenan Professor of Pharmacology at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. Having received his PhD from the University of California at Irvine, Dr. Der went on to complete his postdoctoral research training at the Dana-Farber Cancer Institute and Harvard Medical School. As a two-time PanCAN-AACR grant recipient...

Category: Grantee Story
Learn More